Last month I enjoyed attending my first #MedTech Meeting & my first #PCORI Meeting!! This month I am looking forward to attending my first Liver Meeting!! @childrensnational.bsky.social @aasldnews.bsky.social #WashingtonDC #GrowthStudy #AASLD #AASLD2025
November 2, 2025 at 7:13 PM
Last month I enjoyed attending my first #MedTech Meeting & my first #PCORI Meeting!! This month I am looking forward to attending my first Liver Meeting!! @childrensnational.bsky.social @aasldnews.bsky.social #WashingtonDC #GrowthStudy #AASLD #AASLD2025
ACLF East vs West: APASL—acute insult in CLD → jaundice/INR, liver failure first; HBV common; focus on liver rescue (antivirals, PE, albumin). AASLD/CLIF—decomp cirrhosis w/ multiorgan failure; sepsis/alcohol common; ICU + early LT. Synthesis needed.
#GastroAGI#AASLD2025#ACLF
#GastroAGI#AASLD2025#ACLF
GastroAGI - AI Chat for Gastroenterology Students
Ask AI-powered questions about gastroenterology and enhance your academic learning.
gastroagi.com
January 16, 2026 at 11:23 AM
ACLF East vs West: APASL—acute insult in CLD → jaundice/INR, liver failure first; HBV common; focus on liver rescue (antivirals, PE, albumin). AASLD/CLIF—decomp cirrhosis w/ multiorgan failure; sepsis/alcohol common; ICU + early LT. Synthesis needed.
#GastroAGI#AASLD2025#ACLF
#GastroAGI#AASLD2025#ACLF
What a fantastic Ask the Expert with Dr Joshi! Watch or re-watch this session where Dr Joshi shares PSC research updates from last months international liver conference, AASLD. Full video on our YouTube Channel youtu.be/of0y5GYSugI #LetsBeatPSC #PSCResearch #AASLD2025 #LiverHealth #LiverResearch
December 19, 2025 at 9:01 AM
What a fantastic Ask the Expert with Dr Joshi! Watch or re-watch this session where Dr Joshi shares PSC research updates from last months international liver conference, AASLD. Full video on our YouTube Channel youtu.be/of0y5GYSugI #LetsBeatPSC #PSCResearch #AASLD2025 #LiverHealth #LiverResearch
With #AASLD2025 coming to a close, continue your learning on #ALD with our upcoming free webinar.
Find out more about advances in treatment and what you need to know about the introduction of #MetALD as a new category of liver disease.
👉 buff.ly/XbXhwMi
#HepSky #MedSky
Find out more about advances in treatment and what you need to know about the introduction of #MetALD as a new category of liver disease.
👉 buff.ly/XbXhwMi
#HepSky #MedSky
November 11, 2025 at 4:15 PM
With #AASLD2025 coming to a close, continue your learning on #ALD with our upcoming free webinar.
Find out more about advances in treatment and what you need to know about the introduction of #MetALD as a new category of liver disease.
👉 buff.ly/XbXhwMi
#HepSky #MedSky
Find out more about advances in treatment and what you need to know about the introduction of #MetALD as a new category of liver disease.
👉 buff.ly/XbXhwMi
#HepSky #MedSky
Perspectum is attending AASLD The Liver Meeting 2025!
Visit us at Booth #726 to meet the team and explore how Perspectum supports clinicians, researchers, and patients through innovation in liver health.
#Perspectum #AASLD2025
Visit us at Booth #726 to meet the team and explore how Perspectum supports clinicians, researchers, and patients through innovation in liver health.
#Perspectum #AASLD2025
October 30, 2025 at 1:59 PM
Perspectum is attending AASLD The Liver Meeting 2025!
Visit us at Booth #726 to meet the team and explore how Perspectum supports clinicians, researchers, and patients through innovation in liver health.
#Perspectum #AASLD2025
Visit us at Booth #726 to meet the team and explore how Perspectum supports clinicians, researchers, and patients through innovation in liver health.
#Perspectum #AASLD2025
From genetic correlation to validated mechanism. Our #MASLD program (CTRO-1013) targeting IRS1 was named a Poster of Distinction at #AASLD2025. We used AI on multimodal data from 263K people to find the target, now validated & advancing to IND-enabling studies. www.insitro.com/news/reveali...
Revealing MASLD's Genetic Architecture: Machine Learning, Discovery, and the Path to IRS1 - insitro
Last week, insitro’s work on IRS1 was recognized as a Poster of Distinction at The Liver Meeting 2025. But the real story isn’t about recognition. It’s about learning to see...
www.insitro.com
November 20, 2025 at 5:35 PM
From genetic correlation to validated mechanism. Our #MASLD program (CTRO-1013) targeting IRS1 was named a Poster of Distinction at #AASLD2025. We used AI on multimodal data from 263K people to find the target, now validated & advancing to IND-enabling studies. www.insitro.com/news/reveali...
Genomic data offers correlation in abundance. Causation requires experimental proof at every step. Join insitro at #AASLD2025. On Monday, 1pm, Poster 4013: learn how platform integration of AI, patient-derived biology & staged validation narrow the gap for MASLD therapeutics.
November 8, 2025 at 12:36 AM
Genomic data offers correlation in abundance. Causation requires experimental proof at every step. Join insitro at #AASLD2025. On Monday, 1pm, Poster 4013: learn how platform integration of AI, patient-derived biology & staged validation narrow the gap for MASLD therapeutics.